Table 3.
Characteristics of discontinued users
| Characteristic, n (%) | DF (N = 32) | DDMF (N = 59) |
|---|---|---|
| When did you start therapy?, n (%) | ||
| Within the last 7 days | 0 (0.0 %) | 1 (1.7 %) |
| Between 8 and 30 days ago | 0 (0.0 %) | 5 (8.5 %) |
| Between 31 and 60 days ago | 1 (3.1 %) | 2 (3.4 %) |
| More than 60 days ago | 31 (96.9 %) | 51 (86.4 %) |
| When did you stop therapy?, n (%) | ||
| Within the last 7 days | 0 (0.0 %) | 2 (3.4 %) |
| Between 8 and 30 days ago | 1 (3.1 %) | 14 (23.7 %) |
| Between 31 and 60 days ago | 3 (9.4 %) | 8 (13.6 %) |
| More than 60 days ago | 28 (87.5 %) | 35 (59.3 %) |
| Reasons stopped taking therapya, n (%) | ||
| Side effects | 14 (43.8 %) | 46 (78.0 %) |
| Doctor advice | 8 (25.0 %) | 14 (23.7 %) |
| Lack of effectiveness in treating MS | 8 (25.0 %) | 13 (22.0 %) |
| Concerns regarding the safety | 5 (15.6 %) | 5 (8.5 %) |
| Struggled to take therapy as prescribed | 1 (3.1 %) | 3 (5.1 %) |
| Financial reasons | 1 (3.1 %) | 2 (3.4 %) |
| Did not want to take oral treatment | 0 (0.0 %) | 1 (1.7 %) |
| Changes to health plan benefits | 1 (3.1 %) | 0 (0.0 %) |
| Another reason not listed | 6 (18.8 %) | 7 (11.9 %) |
| Main reason stopped taking therapy, n (%) | ||
| Side effects | 15 (46.9 %) | 40 (67.8 %) |
| Lack of effectiveness in treating MS | 8 (25.0 %) | 9 (15.3 %) |
| Doctor advice | 2 (6.3 %) | 3 (5.1 %) |
| Concerns regarding safety | 2 (6.3 %) | 0 (0.0 %) |
| Financial reasons | 0 (0.0 %) | 1 (1.7 %) |
| Another reason not listed | 5 (15.6 %) | 6 (10.2 %) |
| Who mainly made decision to discontinue therapy?, n (%) | ||
| Mainly my decision | 9 (28.1 %) | 24 (40.7 %) |
| Mainly doctor decision | 7 (21.9 %) | 8 (13.6 %) |
| Joint decision | 16 (50.0 %) | 27 (45.8 %) |
aParticipants could select more than one response